Maybe another contributor to the relatively poor tumor response rate (apart from prior TACE) was the dose given.
Recommended doses I found from Dezarn et al 2011 for Y90
Est degree of liver involvement
>50% 3000 MBq
25-50 2500 MBq
<25% 2000 MBq
By comparison page 20 gives delivered doses of just 1394.5 MBq in the study
There may be reasons for the lower doses, such as shunting of blood flow to other organs, or problems caused by prior treatment with TACE, but surely the lower dose will be less effective.
- Forums
- ASX - By Stock
- SRX
- Sirt result
Sirt result, page-77
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
17.5¢ | 17.5¢ | 17.5¢ | $1.602K | 9.154K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 3847679 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 2509481 | 36 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 2847679 | 0.175 |
6 | 1607688 | 0.170 |
1 | 18186 | 0.165 |
1 | 11500 | 0.145 |
1 | 2577 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 2509481 | 36 |
0.185 | 42357 | 5 |
0.190 | 198822 | 8 |
0.195 | 20478 | 2 |
0.200 | 427416 | 7 |
Last trade - 15.19pm 23/08/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online